Stalfort John A III

Acumen Pharmaceuticals, Inc. · Director

Stalfort John A III is listed in public filings as director. This Stalfort John A III insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Acumen Pharmaceuticals, Inc. (ABOS), Taysha Gene Therapies, Inc. (TSHA), and Verrica Pharmaceuticals Inc. (VRCA). Investors use Stalfort John A III's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Acumen Pharmaceuticals, Inc.ABOS--220.6k sharesGrant / ExerciseJun 3, 2026Disclosure amount unavailable35.5k shares----
Acumen Pharmaceuticals, Inc.ABOS$122k53.3k sharesGrant / ExerciseJun 3, 2026$121.9K53.3k shares$2.29--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Taysha Gene Therapies, Inc.TSHA$255k42.7k sharesGrant / ExerciseJun 1, 2026$254.7K42.7k shares$5.97--
Taysha Gene Therapies, Inc.TSHA--1.2M sharesGrant / ExerciseJun 1, 2026Disclosure amount unavailable21.3k shares----
Acumen Pharmaceuticals, Inc.ABOS--185.1k sharesGrant / ExerciseJun 4, 2025Disclosure amount unavailable12.8k shares----
Acumen Pharmaceuticals, Inc.ABOS$21k19.5k sharesGrant / ExerciseJun 4, 2025$20.9K19.5k shares$1.07--
Taysha Gene Therapies, Inc.TSHA$315k113.2k sharesGrant / ExerciseJun 2, 2025$315.4K113.2k shares$2.79--
Taysha Gene Therapies, Inc.TSHA--1.2M sharesGrant / ExerciseJun 2, 2025Disclosure amount unavailable56.6k shares----
Verrica Pharmaceuticals Inc.VRCA--1.9M sharesGrant / ExerciseNov 26, 2024Disclosure amount unavailable50k shares----
Verrica Pharmaceuticals Inc.VRCA$1.6M1.8M sharesBuyNov 22, 2024$1.0M1.1M shares$0.89--
Verrica Pharmaceuticals Inc.VRCA$750k561.8k sharesBuyNov 22, 2024$750.0K561.8k shares$1.34--
Verrica Pharmaceuticals Inc.VRCA$600k561.8k sharesBuyNov 22, 2024$600.0K561.8k shares$1.07--
Acumen Pharmaceuticals, Inc.ABOS$66k25k sharesGrant / ExerciseJun 10, 2024$65.5K25k shares$2.62--